96765 ⎘
Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Sub-classes:NOVEL PEPTIDE FOR TREATING AN INFECTIOUS DISEASE OR CONDITION
#2NOVEL PEPTIDIC LINKERS AND CRYPTOPHYCIN CONJUGATES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
#3DEPSIPEPTIDE-BASED AMPHIPHILIC BULIDING BLOCK TO INHIBIT PROTEIN-PROTEIN INTERACTIONS, NANOSTRUCTURE COMPRISED THEREOF AND USES THEREOF
#4PEPTIDE-COMPOUND CYCLIZATION METHOD
#5Process for the preparation of cyclic depsipeptides
#6THERAPEUTIC PEPTIDES
#7Netrin G1 And Netrin G1 Ligand Peptides And Antibodies And Uses Thereof
#8A Self-Assembling Short Amphiphilic Peptide And Related Methods And Uses
#9Process for the preparation of cyclic depsipeptides
#10Compositions comprising a PCSK9 peptide conjugated to a qbeta carrier and methods of using the same
#11Cryptophycin antibody conjugates for the treatment of cancer
#12Peptide-compound cyclization method
#13Apratyramide therapeutic agents and methods of treatment
#14Process for the preparation of cyclic depsipeptides
#15PEPTIDES AND NEMATICIDAL COMPOSITIONS
#16NOVEL PEPTIDIC LINKERS AND CRYPTOPHYCIN CONJUGATES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
#17Cryptophycin antibody conjugates for the treatment of cancer
#18Methods of treating chronic and neuropathic pain mediated by N-type neuronal calcium channels using D-enantiomeric peptides
#19Process for the preparation of cyclic depsipeptides
#20Composition comprising PCSK9 peptide conjugated to a Qbeta carrier and methods of using the same
#21Neuropeptide S receptor (NPSR) agonists
#22Butelase-mediated peptide ligation
#23MCJ agonists and uses therefor
#24SELF-ASSEMBLING ULTRASHORT ALIPHATIC DEPSIPEPTIDES FOR BIOMEDICAL APPLICATIONS
#25PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same
#26Modified antibiotic peptides having variable systemic release
#27PEPTIDE-COMPOUND CYCLIZATION METHOD
#28Glycopeptide compound or pharmaceutical salt thereof and method for preparing same, and pharmaceutical compositions and applications thereof
#29Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates
#30Method for producing cereulide and derivative thereof, intermediate for production of cereulide, and cereulide derivative
#31ALDEHYDE ACETAL BASED PROCESSES FOR THE MANUFACTURE OF MACROCYCLIC DEPSIPEPTIDES AND NEW INTERMEDIATES
#32Macrocyclic compounds useful as inhibitors of histone deacetylases
#33Processes for the manufacture of macrocyclic depsipeptides and new intermediates
#34Obesity-related genes and their proteins and uses thereof
#35Macrocyclic compounds useful as inhibitors of histone deacetylases
#36Processes for the manufacture of macrocyclic depsipeptides and new intermediates
#37Protease inhibitors, compositions and methods of use
#38Isolation, Purification, and Structure Elucidation of the Antiproliferative Compound Coibamide A
#39CYCLIC DEPSIPEPTIDE COMPOUND AND USE THEREOF
#40METABOLITE DERIVATIVES OF THE HDAC INHIBITOR FK228
#41Depsipeptide containing lactic acid residue
#42Temperature responsive depsipeptide polymer
#43Isolation, purification, and structure elucidation of the antiproliferative compound coibamide A
#44Tamandarin analogs and fragments thereof and methods of making and using
#45Metabolite derivatives of the HDAC inhibitor FK228
#46Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them
#47Didemnin analogs and fragments and methods of making and using them
#48Depsipeptide compound